Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1466]

ECC 2015: Drug combination improves progression-free survival in melanoma patients regardless of genetic status, age and spread of disease

ECC 2015: Drug combination improves progression-free survival in melanoma patients regardless of genetic status...

ECC 2015:  A combination of two targeted therapies results in melanoma patients living significantly longer: new results

ECC 2015:  A combination of two targeted therapies results in melanoma patients living significantly longer: new...

New method fine tunes proton beam therapy

New method fine tunes proton beam therapy

Researchers identify protein, may predict who will respond to PD-1 immunotherapy for melanoma

Researchers identify protein, may predict who will respond to PD-1 immunotherapy for melanoma

Immune system-boosting agent CpG-B reduced early-stage melanoma recurrences

Immune system-boosting agent CpG-B reduced early-stage melanoma recurrences

Frequency of certain immune cells in blood may predict metastatic melanoma response to pembrolizumab

Frequency of certain immune cells in blood may predict metastatic melanoma response to pembrolizumab

Building a better healthcare future through collaboration and technology

Building a better healthcare future through collaboration and technology

Presence of genetic mutation across several tumour types may help develop more precise anti-cancer therapies

Presence of genetic mutation across several tumour types may help develop more precise anti-cancer therapies

Thousands of patients missing out on targeted cancer drugs

Thousands of patients missing out on targeted cancer drugs

New non-invasive skin cancer test put to the test

New non-invasive skin cancer test put to the test

More from ecancer